European Stock Markets Rise – EuroStoxx 50 Nears Record High

US Stocks in Focus

On Wall Street, Bristol Myers Squibb shares drew attention. The US pharmaceutical giant came under pressure after British competitor AstraZeneca presented positive study results for a cancer drug. Industry observers interpreted this as a potential attack on a high-revenue blockbuster from Bristol Myers Squibb and spoke of intensified competition in oncology.

Bristol Myers Squibb's stock lost significant value in New York, while AstraZeneca was able to gain in London. Analysts see the new study data as evidence that innovative strength in the pharmaceutical sector is increasingly being shaped by European manufacturers. Other US competitors also came under selling pressure.

Diplomacy and Energy Prices

A sell recommendation from Swiss major bank UBS attracted additional attention. UBS analyst Patrick Hummel wrote that the automaker was making too little progress in an improving business environment. "In einem sich verbessernden Geschäftsumfeld mache der Automobilhersteller zu wenige Fortschritte, schrieb Analyst Patrick Hummel. Was bei höheren abgesetzten Volumina am Ende unten ankomme, sei erstaunlich wenig." The stock subsequently fell to its lowest level in months.

On the macroeconomic front, investors looked to new Purchasing Managers' Indices for the eurozone. The data signalled a continued recovery in industry, although the pace fell short of some economists' expectations. Economists see this as confirmation that the European Central Bank could maintain its current monetary policy course for the time being.

Outlook for the Trading Week

Politically, the Middle East moved back into sharper focus. Donald Trump announced a new round of talks with representatives of the Islamic Republic of Iran after another military strike was provisionally called off. In financial markets, such a move is typically interpreted as a stability signal for energy prices.

On the foreign exchange market, the euro last traded at 1.1780 US dollars, slightly firmer than on Friday evening. The common currency benefited from the friendly risk sentiment in equity markets. In the bond market, yields on ten-year Bunds remained virtually unchanged.

On the commodities market, North Sea Brent crude edged slightly higher. Gold, by contrast, fell to its lowest level since the beginning of July. Market participants attributed the decline to the prospect of a possible diplomatic rapprochement between the United States and Iran, which could reduce geopolitical risks.

For the coming trading days, observers expect heightened volatility. In addition to further negotiations between Washington and Tehran, quarterly results from several European industrial groups and the US Federal Reserve meeting are on the agenda. Depending on their signals, the EuroStoxx 50 may or may not surpass its record in the days ahead.

In the afternoon, attention shifted increasingly to Wall Street, where the leading Dow Jones Industrial Average edged slightly higher. The technology-heavy Nasdaq indices also started on a friendly note, driven by gains in semiconductor stocks. Sentiment on US bourses is regarded by many market participants as a key pacemaker for European indices as well.